Results 1 to 10 of about 9,116 (165)

Labetalol-Induced Hepatotoxicity during Pregnancy: A Case Report

American Journal of Perinatology Reports, 2020
Background Drug-induced liver injury is a common cause of transaminitis, occurring in up to 5% of patients who are hospitalized for liver failure. In pregnancy, transaminitis is seen in conditions which may require expedited delivery.
Anna Whelan, Joanna Izewski, Charles Berkelhammer, Jami Walloch, Helen H. Kay   +4 more
doaj   +2 more sources

Raynaud's phenomenon of the nipple as a side-effect of labetalol: Case report and literature review

Case Reports in Women's Health, 2019
Raynaud's phenomenon of the nipple is an unusual side-effect of labetalol use. There is one official report from the United Kingdom. The present case concerns a 30-year-old woman, gravida 1, para 0, who developed pre-eclampsia and was treated with ...
Jesus Avila-Vega, Enrique Urrea-Mendoza, Christy Lee   +2 more
doaj   +1 more source

A Comparison of Labetalol and Nitroglycerin for The Management of Intraoperative Hypertension in Ambulatory Surgical Patients Who Underwent Cataract Surgery

Archives of Anesthesia and Critical Care, 2018
Background: This is a prospective randomized blinded clinical trial comparing the efficacy and safety of labetalol and nitroglycerin for the management of intraoperative hypertension in ambulatory surgical patients who underwent cataract surgery. Methods:
Mehdi Sanatkar, Hossein Sadrossadat, Mehrdad Goudarzi, Ebrahim Espahbodi, Masoumeh Zangeneh   +4 more
doaj   +1 more source

ACUTE MANAGEMENT OF HYPERTENSIVE EMERGENCIES IN PREGNANCY: ORAL NIFEDIPINE VERSUS INTRAVENOUS LABETALOL

Pakistan Armed Forces Medical Journal, 2018
Objective: To compare the outcome of oral Nifedipine & intravenous Labetalol in severe pregnancy induced hypertension in terms of time taken to achieve the target blood pressure. Study Design: Randomized controlled trial.
Riffat Sarwar, Nilofar Mustafa, Saima Qamar, Omar Zafar   +3 more
doaj   +4 more sources

Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes

Frontiers in Pharmacology, 2021
Pregnancy-related hormones (PRH) are recognized as important regulators of hepatic cytochrome P450 enzyme expression and function. However, the impact of PRH on the hepatic expression and function of uridine diphosphate glucuronosyltransferases (UGTs ...
Raju Khatri, John K. Fallon, Craig Sykes, Natasha Kulick, Rebecca J. B. Rementer, Taryn A. Miner, Amanda P. Schauer, Angela D. M. Kashuba, Kim A. Boggess, Kim L. R. Brouwer, Philip C. Smith, Craig R. Lee   +11 more
doaj   +1 more source

Comparative evaluation between two methods of induced hypotension with infusion of Remifentanil and Labetalol during sinus endoscopy

Journal of Research in Pharmacy Practice, 2016
Objective: This study aimed to compare two methods of controlled hypotension using labetalol and remifentanil in terms of capability to create controlled hypotension and to investigate the obtained complications, and satisfaction rate of surgeon and ...
Parvin Sajedi, Ali Rahimian, Gholamreza Khalili   +2 more
doaj   +1 more source

Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis

Hypertension in Pregnancy, 2023
Aim To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP). Methods The primary outcomes were the required time to achieve target blood pressure (RTATBP), systolic blood pressure (SBP) and ...
Minghui Ou, Futao Zhang, Shichao Cui, Shibo Zhao, Yan Yu   +4 more
doaj   +1 more source

COMPARISON OF HYDRALAZINE AND LABETALOL IN THE MANAGEMENT OF HYPERTENSIVE DISORDERS OF PREGNANCY

Pakistan Armed Forces Medical Journal, 2022
Objective: To compare the efficacy of intravenous hydralazine and intravenous labetalol for acutely lowering blood pressure in pregnancy. Study Design: Randomized control trial (RCT).
Humaira Osman Jaffery, Kausar Tasleem Bangash   +1 more
doaj   +2 more sources

Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients

Journal of International Medical Research, 2023
Objectives Current evidence supporting the use of continuous intravenous labetalol for blood pressure (BP) control in neurosurgical patients is limited. This study aims to assess the efficacy and safety of labetalol in neurosurgical patients and identify
Raywat Noiphithak , Gahn Duangprasert , Sasikan Sukhor , Pichayaphong Durongkaweroj, Vich Yindeedej   +4 more
doaj   +1 more source

A comparative study of intravenous labetalol VS intravenous nitroglycerin in the treatment of hypertensive crises

Indian Heart Journal, 2022
Hypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but ...
Mohammad Azharuddin Malik, Rehan Ahmad, Mujahid Beg, Rizwan Ahmad   +3 more
doaj   +1 more source